Vlad DC

ORCID: 0000-0002-9243-1865 · 2 papers in corpus
2025
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol32060336

Background and Objectives: As a leading European country in terms of cervical cancer incidence and mortality, there has been a pressing need for Romania to upgrade its cervical cancer management. The criteria set by the International Federa…

2025
Cancers ·doi:10.3390/cancers18010073

Background/Objectives: Aromatase inhibitors (AIs)-specifically, letrozole, anastrozole and exemestane-represent the current gold standard for patients with estrogen-receptor-positive breast cancer (ER + BC). This narrative review highlights…